M

Milestone Pharmaceuticals
D

MIST

2.40500
USD
-0.56
(-18.75%)
مغلق
حجم التداول
803,594
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
204,832,272
الأخبار المقالات

العنوان: Milestone Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal sprayto be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).